Big Data and Analytics

Digital Twin technology, or the application of predictive analytics to fields as diverse as manufacturing and space science, is now being considered in the context of healthcare. The attraction is obvious: if one can develop a computer model of a patient, perhaps one can test treatments on the model before applying them to the individual. Rather t...

Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...

Dental practice management software (DPMS) solutions are digital tools used by dentists and related health professionals to oversee their day-to-day clinic operations. These solutions are designed to streamline core operations such as appointments, scheduling, and billing and help dentists focus more on patient care. Many dental clinics devote cons...

US-based providers lose an estimated $260 billion to $270 billion annually due to poor financial risk management and lack of infrastructure to support data-driven business decisions. For every dollar claimed, private and public payers on average offer a reimbursement of 86 cents to providers, resulting in a negative margin of 14% per dollar per pat...

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

Global resource constraints on health systems are driving a shift to value-based healthcare to reduce cost, increase access, and improve outcomes. In the United States, resource constraints affect more than 20% of the population. The number of respiratory therapists is declining at a rate of 4% to 7%, while the demand for respiratory specialists wi...

Conventional visualization methods that depend on two-dimensional (2D) medical images have been fraught with challenges such as difficulty in interpreting the information due to the static nature of the content and lack of availability of volumetric data. To address these limitations, imaging preferences of the medical community are shifting toward...

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the $2 trillion mark in 2020. Healthcare will be among the top two priorities for voters in the 2020 presidential election in the US. In the European region, looming BREXIT indecision is likely to have a strong impact o...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...